Erratum to "Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): Results of a serial follow-up CT study" [Radiother Oncol 85 (2007) 435-442] (DOI:10.1016/j.radonc.2007.10.044);Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): Results of a serial follow-up CT study

Radiotherapy and Oncology

Volumn 85, Issue 3, 2007, Pages 435-442

  Guckenberger, Matthias ^a   Heilman, Katrin ^a   Wulf, Joern ^b   Mueller, Gerd ^a   Beckmann, Gabriele ^a   Flentje, Michael ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Lindenhofspital   (Switzerland)

Author keywords

CT follow up; Pulmonary fibrosis; Radiation pneumonitis; Response; Stereotactic radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LUNG INJURY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; RADIOSURGERY; RECURRENT DISEASE; STEREOTACTIC BODY RADIOTHERAPY; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR DIFFERENTIATION; WHOLE BODY RADIATION;

EID: 36749019597     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.01.016     Document Type: Erratum

References (47)

1. Aoki T., Nagata Y., Negoro Y., et al. Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors: CT appearance. Radiology 230 (2004) 101-108
2. Beitler J.J., Badine E.A., El-Sayah D., et al. Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years. Int J Radiat Oncol Biol Phys 65 (2006) 100-106
3. Belderbos J.S., Heemsbergen W.D., De Jaeger K., Baas P., and Lebesque J.V. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 126-134
4. Blomgren H., Lax I., Naslund I., and Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34 (1995) 861-870
5. Bradley J., Graham M.V., Winter K., et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 318-328
6. Fritz P., Kraus H.J., Muhlnickel W., et al. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol 1 (2006) 30
7. Fuss M., Salter B.J., Rassiah P., Cheek D., Cavanaugh S.X., and Herman T.S. Repositioning accuracy of a commercially available double-vacuum whole body immobilization system for stereotactic body radiation therapy. Tech Cancer Res Treat 3 (2004) 59-67
8. Guckenberger M., Meyer J., Wilbert J., et al. Cone-beam CT based image-guidance for extracranial stereotactic radiotherapy of intrapulmonary tumors. Acta Oncol 45 (2006) 897-906
9. Guckenberger M., Meyer J., Wilbert J., et al. Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. Radiother Oncol 83 (2007) 57-64
10. Guckenberger M., Wilbert J., Krieger T., et al. Four-dimensional treatment planning for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 69 (2007) 276-285
11. Haedinger U., Krieger T., Flentje M., and Wulf J. Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets. Int J Radiat Oncol Biol Phys 61 (2005) 239-249
12. Hanley J., Debois M.M., Mah D., et al. Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. Int J Radiat Oncol Biol Phys 45 (1999) 603-611
13. Hara R., Itami J., Kondo T., et al. Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors. Cancer 106 (2006) 1347-1352
14. Hof H., Herfarth K.K., Munter M., Essig M., Wannenmacher M., and Debus J. The use of the multislice CT for the determination of respiratory lung tumor movement in stereotactic single-dose irradiation. Strahlenther Onkol 179 (2003) 542-547
15. Hof H., Herfarth K.K., Munter M., et al. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 56 (2003) 335-341
16. Hoopes D.J., Tann M., Fletcher J.W., et al. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Lung Cancer 56 (2007) 229-234
17. Kimura T., Matsuura K., Murakami Y., et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers?. Int J Radiat Oncol Biol Phys 66 (2006) 483-491
18. Krieger T., and Sauer O.A. Monte Carlo-versus pencil-beam-/collapsed-cone-dose calculation in a heterogeneous multi-layer phantom. Phys Med Biol 50 (2005) 859-868
19. Lax I., Blomgren H., Naslund I., and Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 33 (1994) 677-683
20. Lax I., Panettieri V., Wennberg B., et al. Dose distributions in SBRT of lung tumors: comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motions. Acta Oncol 45 (2006) 978-988
21. McGarry R.C., Papiez L., Williams M., Whitford T., and Timmerman R.D. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 63 (2005) 1010-1015
22. Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 63 (2005) 5-24
23. Miller K.L., Shafman T.D., Anscher M.S., et al. Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer?. Int J Radiat Oncol Biol Phys 61 (2005) 64-69
24. Minohara S., Kanai T., Endo M., Noda K., and Kanazawa M. Respiratory gated irradiation system for heavy-ion radiotherapy. Int J Radiat Oncol Biol Phys 47 (2000) 1097-1103
25. Miyamoto T., Baba M., Yamamoto N., et al. Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys 67 (2007) 750-758
26. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63 (2005) 1427-1431
27. Nyman J., Johansson K.A., and Hulten U. Stereotatic hypotractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients. Lung Cancer 51 (2006) 97-103
28. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I non small cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
29. Onishi H., Kuriyama K., Komiyama T., et al. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer 45 (2004) 45-55
30. Panettieri V., Wennberg B., Gagliardi G., Duch M.A., Ginjaume M., and Lax I. SBRT of lung tumours: Monte Carlo simulation with PENELOPE of dose distributions including respiratory motion and comparison with different treatment planning systems. Phys Med Biol 52 (2007) 4265-4281
31. Patz Jr. E.F., Lowe V.J., Hoffman J.M., Paine S.S., Harris L.K., and Goodman P.C. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-d-glucose. Radiology 191 (1994) 379-382
32. Purdie T.G., Bissonnette J.P., Franks K., et al. Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: Localization, verification, and intrafraction tumor position. Int J Radiat Oncol Biol Phys 68 (2007) 243-252
33. Senan S., Haasbeek N.J., Smit E.F., and Lagerwaard F.J. Stereotactic radiotherapy for centrally located early-stage lung tumors. J Clin Oncol 25 (2007) 464 author reply 465
34. Takeda T., Takeda A., Kunieda E., et al. Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: serial changes on CT. AJR Am J Roentgenol 182 (2004) 1123-1128
35. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
36. Timmerman RD. RTOG 0236: a phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I/II non-small cell lung cancer 2006.
37. Uematsu M., Shioda A., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 51 (2001) 666-670
38. Underberg R.W., Lagerwaard F.J., Slotman B.J., Cuijpers J.P., and Senan S. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets. Int J Radiat Oncol Biol Phys 62 (2005) 554-560
39. Wong J.W., Sharpe M.B., Jaffray D.A., et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys 44 (1999) 911-919
40. Wulf J., Baier K., Mueller G., and Flentje M.P. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 77 (2005) 83-87
41. Wulf J., Hadinger U., Oppitz U., Olshausen B., and Flentje M. Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother Oncol 57 (2000) 225-236
42. Wulf J., Hadinger U., Oppitz U., Thiele W., and Flentje M. Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver. Radiother Oncol 66 (2003) 141-150
43. Wulf J., Hadinger U., Oppitz U., Thiele W., Ness-Dourdoumas R., and Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177 (2001) 645-655
44. Wulf J., Haedinger U., Oppitz U., Thiele W., Mueller G., and Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 60 (2004) 186-196
45. Xia T., Li H., Sun Q., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66 (2006) 117-125
46. Yamashita H., Nakagawa K., Nakamura N., et al. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2 (2007) 21
47. Zimmermann F.B., Geinitz H., Schill S., et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 48 (2005) 107-114